Table 4 Reactome pathways enriched with genes involved in the top 1% subnetworks obtained when considering binary and co-complex interactions.

From: Gene network and biological pathways associated with susceptibility to differentiated thyroid carcinoma

Interactions type

Enriched reactome pathway

Genes (N)

PEMPa

PFDRb

Binary

Striated muscle contraction

7

2.2 × 10–10

7.3 × 10–08

Muscle contraction

9

3.6 × 10–07

5.9 × 10–05

Glycogen breakdown (glycogenolysis)

3

7.3 × 10–05

7.9 × 10–03

Glycogen metabolism

3

3.2 × 10–04

2.5 × 10–02

The role of GTSE1 in G2/M progression after G2 checkpoint

4

3.9 × 10–04

2.5 × 10–02

Co-complex

Peptide chain elongation

37

4.4 × 10–53

1.2 × 10–50

Viral mRNA translation

37

4.4 × 10–53

1.2 × 10–50

Formation of a pool of free 40S subunits

38

1.6 × 10–52

3.0 × 10–50

Eukaryotic translation elongation

37

3.4 × 10–52

3.1 × 10–50

Selenocysteine synthesis

37

3.4 × 10–52

3.1 × 10–50

Eukaryotic translation termination

37

3.4 × 10–52

3.1 × 10–50

Nonsense mediated decay (NMD) independent of the exon junction complex (EJC)

37

9.1 × 10–52

7.2 × 10–50

L13a-mediated translational silencing of ceruloplasmin expression

38

1.3 × 10–50

8.7 × 10–49

GTP hydrolysis and joining of the 60S ribosomal subunit

38

1.9 × 10–50

1.2 × 10–48

Nonsense-mediated decay (NMD)

38

6.3 × 10–50

3.1 × 10–48

Nonsense mediated decay (NMD) enhanced by the exon junction complex (EJC)

38

6.3 × 10–50

3.1 × 10–48

Eukaryotic translation initiation

38

2.9 × 10–49

1.2 × 10–47

Cap-dependent translation initiation

38

2.9 × 10–49

1.2 × 10–47

SRP-dependent cotranslational protein targeting to membrane

37

1.5 × 10–48

5.9 × 10–47

Selenoamino acid metabolism

37

1.5 × 10–47

5.3 × 10–46

Influenza viral RNA transcription and replication

38

4.0 × 10–47

1.4 × 10–45

Major pathway of rRNA processing in the nucleolus and cytosol

41

5.8 × 10–47

1.9 × 10–44

Regulation of expression of SLITs and ROBOs

40

8.3 × 10–46

2.5 × 10–44

Influenza life cycle

38

9.3 × 10–46

2.7 × 10–44

rRNA processing in the nucleus and cytosol

41

6.2 × 10–45

1.7 × 10–43

Influenza Infection

38

2.2 × 10–44

5.8 × 10–43

rRNA processing

41

5.8 × 10–44

1.5 × 10–42

Signaling by ROBO receptors

40

3.2 × 10–41

7.8 × 10–40

Translation

40

5.9 × 10–36

1.6 × 10–34

Infectious disease

41

1.9 × 10–32

4.2 × 10–31

Metabolism of amino acids and derivatives

39

1.9 × 10–30

4.1 × 10–29

Formation of the ternary complex, and subsequently, the 43S complex

19

5.1 × 10–26

1.0 × 10–24

Translation initiation complex formation

19

9.4 × 10–25

1.8 × 10–23

Ribosomal scanning and start codon recognition

19

9.4 × 10–25

1.8 × 10–23

Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S

19

1.4 × 10–24

2.5 × 10–23

TCR signaling

6

1.1 × 10–3

2.0 × 10–2

Regulation of mRNA stability by proteins that bind AU-rich elements

5

1.7 × 10–3

3.0 × 10–2

FBXL7 down-regulates AURKA during mitotic entry and in early mitosis

4

1.9 × 10–3

3.2 × 10–2

Insulin receptor recycling

3

2.1 × 10–3

3.3 × 10–2

Regulation of RUNX3 expression and activity

4

2.1 × 10–3

3.3 × 10–2

Insulin processing

3

2.3 × 10–3

3.5 × 10–2

Stabilization of p53

4

2.4 × 10–3

3.5 × 10–2

Iron uptake and transport

4

2.5 × 10–3

3.7 × 10–2

Downstream TCR signaling

5

2.8 × 10–3

3.9 × 10–2

G2/M transition

7

3.0 × 10–3

4.2 × 10–2

Mitotic G2-G2/M phases

7

3.2 × 10–3

4.2 × 10–2

rRNA modification in the nucleus and cytosol

4

3.2 × 10–3

4.2 × 10–2

Transferrin endocytosis and recycling

3

3.4 × 10–3

4.4 × 10–2

Cilium assembly

7

3.5 × 10–3

4.4 × 10–2

ROS, RNS production in phagocytes

3

3.8 × 10–3

4.6 × 10–2

p53-dependent G1 DNA damage response

4

4.0 × 10–3

4.7 × 10–2

p53-dependent G1/S DNA damage checkpoint

4

4.0 × 10–3

4.7 × 10–2

  1. aEmpirical p-value of the association test with DTC risk at the pathway level.
  2. bp-value of the association test with DTC risk at the pathway level, after FDR correction.